In this webinar, the 5th installment in our East Horizon – R Code Integration series, J. Kyle Wathen and Valeria Mazzanti will focus on the concept of Assurance in the context of R&D investment viability. We will compare using non-informative versus informative assurance priors to evaluate the cost-effectiveness of a clinical trial, and to ensure that continued investment is justified. East Horizon’s R Integration feature will be used to adjust the way patient outcomes are simulated while accounting for uncertainty around the true treatment effect.

Key topics

• Informed Priors & Assurance
• Simulation-Driven Study Design
• Commercial software + bespoke R code
• Confident R&D investment

Speakers

• J. Kyle Wathen, Vice President, Scientific Strategy & Innovation
• Valeria Mazzanti, Associate Director, Customer Success